Rules Mate

Conduct post-market surveillance of therapeutic goods

ARTG-included goods must be monitored post-market for safety + performance.

criticalcurrentongoingCriminal liability

Who must comply

ARTG sponsors + manufacturers (medicines + devices + biologicals).

What triggers it

Inclusion of goods in the ARTG.

When due

Continuous; adverse-event reports per timeframes; periodic safety updates.

Evidence required

PMS plan; adverse-event register; safety updates; recall procedure.

Max penalty

Civil + criminal penalties (up to $1.65M / $16.5M); ARTG cancellation

Summary

Part 5-1 Therapeutic Goods Act + ARTG conditions require sponsors to conduct post-market surveillance — adverse-event reporting, safety updates, recall when warranted. Medical-device manufacturers operate quality management systems aligned to ISO 13485 with TGA conformity assessment.

Enforced by

Source legislation

Industries

Topics

medicinespmstga

Related obligations

Frequently asked questions

Who must comply with post-market surveillance of therapeutic goods?
ARTG sponsors + manufacturers (medicines + devices + biologicals).
What triggers post-market surveillance of therapeutic goods?
Inclusion of goods in the ARTG.
When is post-market surveillance of therapeutic goods due?
Continuous; adverse-event reports per timeframes; periodic safety updates.
What is the maximum penalty for post-market surveillance of therapeutic goods?
Civil + criminal penalties (up to $1.65M / $16.5M); ARTG cancellation
What evidence is required for post-market surveillance of therapeutic goods?
PMS plan; adverse-event register; safety updates; recall procedure.

Source: https://tga.gov.au/safety/safety-monitoring. Rules Mate is not a law firm. Always verify against the live regulator source before acting.